Substance Name: Labetuzumab [USAN:INN]
RN: 219649-07-7
UNII: EFE6X5M3UY
Note
- Humanized monoclonal antibody to carcinoembryonic antigen that inhibits tumor growth; used in radioimmunotherapy.
Classification Codes
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Monoclonal Antibody
- Treatment of Colorectal Cancer (Humanized Monoclonal Antibody hMN-14 Targeting CEA-Positive Cancers)
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Labetuzumab
- Labetuzumab [USAN:INN]
Synonyms
- CEA-Cide
- hMN-14
- IMMU-100
- Immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 gamma-chain), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer
- Labetuzumab
- MAb hMN14
- Monoclonal antibody hMN-14
- UNII-EFE6X5M3UY
Systematic Name
- Immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 gamma-chain), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 219649-07-7
FDA UNII
- EFE6X5M3UY
System Generated Number
- 0219649077